Inscription Capital’s Colgate-Palmolive CL Stock Holding History

Inscription Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.1M	Sell	48,142 -175	-0.4%	-$15.6K	0.43%	38
2025 Q4	$3.82M	Buy	48,317 +11,837	+32%	+$928K	0.39%	41
2025 Q3	$2.92M	Sell	36,480 -2,294	-6%	-$196K	0.31%	47
2025 Q2	$3.52M	Buy	38,774 +2,467	+7%	+$225K	0.51%	35
2025 Q1	$3.27M	Buy	+36,307	New	+$3.25M	0.54%	36
2024 Q3	$3.57M	Sell	34,376 -2,337	-6%	-$238K	0.53%	38
2024 Q2	$3.56M	Buy	36,713 +406	+1%	+$37.5K	0.57%	33
2024 Q1	$3.27M	Buy	+36,307	New	+$3.08M	0.54%	36
2022 Q3	–	Sell	-2,500	Closed	-$200K	–	209
2022 Q2	$200K	Buy	+2,500	New	+$195K	0.04%	240
2021 Q3	–	Sell	-9,462	Closed	-$770K	–	238
2021 Q2	$770K	Buy	+9,462	New	+$774K	0.09%	153
2019 Q2	–	Sell	-2,730	Closed	-$187K	–	126
2019 Q1	$187K	Buy	2,730 +786	+40%	+$50.8K	0.1%	122
2018 Q4	$116K	Buy	+1,944	New	+$122K	0.06%	155

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Inscription Capital's CL Position: Q1 2026 in Review

Inscription Capital reduced its Colgate-Palmolive (CL) stake by 0.36% in Q1 2026, selling an estimated $15.6K and leaving 48,142 shares worth $4.1M. The position accounts for 0.43% of the portfolio, ranked #38.

Inscription Capital first reported a position in CL in Q4 2018 and has held it in 12 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Inscription Capital held 48,142 shares of Colgate-Palmolive worth $4.1M as of Q1 2026.
Inscription Capital sold 175 Colgate-Palmolive shares in Q1 2026, an estimated $15.6K.
Colgate-Palmolive made up 0.43% of Inscription Capital's portfolio in Q1 2026, its #38 holding.
Inscription Capital first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 12 quarters since.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.